Last reviewed · How we verify
NCT02875678
A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia
Phase 1 trial testing ABX-1431 in Dyspepsia in 4 participants. Terminated before completion.
7 August 2017
Quick facts
| Lead sponsor | Abide Therapeutics |
|---|---|
| Phase | Phase 1 |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 4 |
| Start date | 22 November 2016 |
| Primary completion | 7 August 2017 |
| Estimated completion | 7 August 2017 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- ABX-1431 — full drug profile →
- Placebo
Conditions studied
- Dyspepsia — all drugs for Dyspepsia →
Sponsor
Abide Therapeutics — full company profile →
Who can join
Adults 18 to 65, any sex, with Dyspepsia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A Single-Dose Study to Evaluate the Effects of ABX-1431 on Gastric Accommodation and Nutrient Volume Tolerance in Patients with Functional Dyspepsia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02875678
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ABX-1431
Trials testing the same drug.
- NCT03625453 — Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder · Phase 2 · completed
- NCT03447756 — Titration Study of ABX-1431 · Phase 1 · completed
- NCT03058562 — A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome · Phase 1 · completed
Other recruiting trials for Dyspepsia
Currently open trials in the same condition.
- NCT06941545 — High Resolution Gastric Mapping and Gastroduodenal Manometry · NA · recruiting
- NCT07261228 — The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper · recruiting
- NCT06755671 — A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms · recruiting
- NCT06422052 — Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspep · recruiting
- NCT05810168 — Traditional Dietary Advice Versus Low FODMAP Diet in Postprandial Functional Dyspepsia · NA · recruiting
Other Abide Therapeutics trials
Trials by the same sponsor.
- NCT03625453 — Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder · Phase 2 · completed
- NCT03447756 — Titration Study of ABX-1431 · Phase 1 · completed
- NCT03138421 — Central Pain Study for ABX-1431 · Phase 1 · completed
- NCT03058562 — A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02875678 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Abide Therapeutics
- Last refreshed: 7 September 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02875678.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing